Overview

A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever

Status:
Unknown status
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
This study in order to evaluate the Baicalein Tablets' safety and efficiency for audit with influenza
Phase:
Phase 2
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Treatments:
Baicalein